Report Detail
Global Artificial Intelligence in Drug Discovery Market By Application [Immuno-oncology, Neurodegenerative diseases, Cardiovascular disease, Metabolic diseases and others],By End User [Pharmaceutical & biotechnology companies, Contract research organizations, Research centres and institutes], By Technology[Machine Learning, Computer Vision, Context-Aware Computing and NLP], By Offerings[Services and Softwares]:Market Research Report 2021 : Covid 19 Impact Outlook, Regional Analysis, Competitive
- RnM4285145 |
- 10 February, 2021 |
- Global |
- 215 Pages |
- Transilience Market Research |
- Healthcare
Global Artificial Intelligence in Drug Discovery Market 2020 By Application [Immuno-oncology, Neurodegenerative diseases, Cardiovascular disease, Metabolic diseases and others],By End User [Pharmaceutical & biotechnology companies, Contract research organizations, Research centres and institutes], By Technology[Machine Learning, Computer Vision, Context-Aware Computing and NLP], By Offerings[Services and Softwares]:Global Forecast to 2026 and COVID-19 Impact Outlook
Global Artificial Intelligence in Drug Discovery Market is valued at 202.66 USD Million in 2019 and expected to reach USD 3,890.59 Million by 2026 with the CAGR of 44.68% over the forecast period.
Scope of the report
This report analyses the global market for Artificial Intelligence in Drug Discovery. The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to give complete information on the global scenario. The qualitative and quantitative data provided in this study can help user understand which market segments, regions are expected to grow at higher rates, factors affecting the market and key opportunity areas. The report also includes competitive landscape of key players in the industry along with emerging trends in the market.
Key Players
Microsoft,NVIDIA Corporation,IBM Corporation Atomwise Inc.,DEEP GENOMICS,Numerate,NuMedii Inc.,Envisagenics.,twoXAR Incorporated,OWKIN INC.,XtalPi Inc.,BERG LLC,Cloud Pharmaceuticals Inc.,Insilico Medicine,BenevolentAI Ltd,Exscientia,Cyclica Inc and others
Above mentioned companies were scrutinized to assess competitive landscape of global Artificial Intelligence in Drug Discovery market. Report provides company profiles of each player. Each profile include company product portfolio,business overview, company governance, company financials, business strategies, manufacturing locations and production facilities, company sale, recent developments and strategic collaborations & partnerships, new product launch, company segments, application diversification and company strength and weakness analysis.
Review period:
(2016-2026)
Historic Period: 2016 to 2019
Forecast Period: 2020 to 2026
Base Year: 2019
Unit: USD Million
This Artificial Intelligence in Drug Discovery market report provides insights on new trade regulations, import export analysis, industry value chain analysis, market size, consumption, production analysis, capacity analysis, regional and segment market share, product launches, product pipeline analysis, impact of Covid-19 on supply chain, key regions, untapped markets, patent analysis, product approvals, continuous innovations and developments in the market.
Regions
• North America: U.S., Canada and Rest of North America
• Europe: UK, France, Germany, Italy, Spain and Rest of Europe
• Asia Pacific: China, Japan, India, Australia, Southeast Asia and Rest of Asia Pacific
• Latin America: Brazil, Mexico, Argentina and Rest of Latin America
• Middle East and Africa: Gulf Countries, Israel, Africa and Rest of Middle East and Africa
Market Segmentation
• Application
o Immuno-oncology
o Neurodegenerative diseases
o Cardiovascular disease
o Metabolic diseases
o other
• End User
o Pharmaceutical & biotechnology companies
o Contract research organizations
o Research centres and institutes
• Technology
o Machine Learning
o Computer Vision
o Context-Aware Computing
o NLP
• Offerings
o Services
o Softwares
Report Coverage
• An overview of the global Artificial Intelligence in Drug Discovery market
• In depth analysis of market dynamics and major factors such as drivers, restraints, opportunities and trends influencing the global market
• Global Artificial Intelligence in Drug Discovery market revenue data historic and forecast analysis (2016 to 2026)
• Characterization and quantification of the market segments for Artificial Intelligence in Drug Discovery market
• Market share analysis of key market participants and their competitive landscape
Important Questions Answered by Global Artificial Intelligence in Drug Discovery Market Report
• What is the impact of COVID 19 epidemic on the global Artificial Intelligence in Drug Discovery market?
• Which is mostly affected region, country?
• Which is the current largest and fastest-growing region?
• What is the market size and growth rate of the global Artificial Intelligence in Drug Discovery market?
• What are current factors affecting the growth of market?
• What are Key trends and opportunity areas?
• Within Artificial Intelligence in Drug Discovery market, which segments are fastest growing & emerging strongly? What are the drivers and restraints for each segment? What are vendor competencies by segment?
• What are the major strategies adopted by leading market companies?
• What are company challenges and essential success factors by marketsegment?
• How company offerings and supply chain capabilitiesare shifting to meetemerging market needs?
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. List of Abbreviations
2. Executive Summary
3. Market Overview
- 3.1. Market Definition
- 3.2. Market Scope
- 3.3. Market Drivers
- 3.4. Market Restraints
- 3.5. Market Opportunities and Trends
- 3.6. Porter’s five force analysis
- 3.7. SWOT Analysis
- 3.8. PEST Analysis
- 3.9. Patent Analysis
- 3.10. Impact of COVID 19 on Global Artificial Intelligence in Drug Discovery Market
4. Artificial Intelligence in Drug Discovery Market, By Application, Market Size and Forecast 2016 -2026 (USD Million)
- 4.1. Global Artificial Intelligence in Drug Discovery Market By Application, 2016 -2026 (USD Million)
- 4.1.1. Global Artificial Intelligence in Drug Discovery Market By Immuno-oncology
- 4.1.2. Global Artificial Intelligence in Drug Discovery Market By Neurodegenerative diseases
- 4.1.3. Global Artificial Intelligence in Drug Discovery Market By Cardiovascular disease
- 4.1.4. Global Artificial Intelligence in Drug Discovery Market By Metabolic diseases
- 4.1.5. Global Artificial Intelligence in Drug Discovery Market By other
- 4.2. Global Artificial Intelligence in Drug Discovery Market By Application Share, 2016 -2026 (%)
5. Artificial Intelligence in Drug Discovery Market, By Technology, Market Size and Forecast 2016 -2026 (USD Million)
- 5.1. Global Artificial Intelligence in Drug Discovery Market By Technology, 2016 -2026 (USD Million)
- 5.1.1. Global Artificial Intelligence in Drug Discovery Market By Machine Learning
- 5.1.2. Global Artificial Intelligence in Drug Discovery Market By Computer Vision
- 5.1.3. Global Artificial Intelligence in Drug Discovery Market By Context-Aware Computing
- 5.1.4. Global Artificial Intelligence in Drug Discovery Market By NLP
- 5.2. Global Artificial Intelligence in Drug Discovery Market By Technology Share, 2016 -2026 (%)
6. Artificial Intelligence in Drug Discovery Market, By End User, Market Size and Forecast 2016 -2026 (USD Million)
- 6.1. Global Artificial Intelligence in Drug Discovery Market By End User, 2016 -2026 (USD Million)
- 6.1.1. Global Artificial Intelligence in Drug Discovery Market By Pharmaceutical & biotechnology companies
- 6.1.2. Global Artificial Intelligence in Drug Discovery Market By Contract research organizations
- 6.1.3. Global Artificial Intelligence in Drug Discovery Market By Research centres and institutes
- 6.2. Global Artificial Intelligence in Drug Discovery Market By End User Share, 2016 -2026 (%)
7. Artificial Intelligence in Drug Discovery Market, By Offerings, Market Size and Forecast 2016 -2026 (USD Million)
- 7.1. Global Artificial Intelligence in Drug Discovery Market By Offerings, 2016 -2026 (USD Million)
- 7.1.1. Global Artificial Intelligence in Drug Discovery Market By Services
- 7.1.2. Global Artificial Intelligence in Drug Discovery Market By Softwares
- 7.2. Global Artificial Intelligence in Drug Discovery Market By Offerings Share, 2016 -2026 (%)
8. Artificial Intelligence in Drug Discovery Market, By Region Market Size and Forecast 2016 -2026
- 8.1. NORTH AMERICA
- 8.1.1. Key Findings
- 8.1.2. Impact of COVID 19
- 8.1.3. Key market trends, growth factors and opportunities
- 8.1.4. North America Artificial Intelligence in Drug Discovery Market by Country 2016 -2026 (USD Million)
- 8.1.5. North America Artificial Intelligence in Drug Discovery Market By Application 2016 -2026 (USD Million)
- 8.1.6. North America Artificial Intelligence in Drug Discovery Market By End User 2016 -2026 (USD Million)
- 8.1.7. North America Artificial Intelligence in Drug Discovery Market By Technology 2016 -2026 (USD Million)
- 8.1.8. North America Artificial Intelligence in Drug Discovery Market By Offerings 2016 -2026 (USD Million)
- 8.2. EUROPE
- 8.2.1. Key Findings
- 8.2.2. Impact of COVID 19
- 8.2.3. Key market trends, growth factors and opportunities
- 8.2.4. Europe Artificial Intelligence in Drug Discovery Market by Country 2016 -2026 (USD Million)
- 8.2.5. Europe Artificial Intelligence in Drug Discovery Market By Application 2016 -2026 (USD Million)
- 8.2.6. Europe Artificial Intelligence in Drug Discovery Market By End User 2016 -2026 (USD Million)
- 8.2.7. Europe Artificial Intelligence in Drug Discovery Market By Technology 2016 -2026 (USD Million)
- 8.2.8. Europe Artificial Intelligence in Drug Discovery Market By Offerings 2016 -2026 (USD Million)
- 8.3. ASIA PACIFIC
- 8.3.1. Key Findings
- 8.3.2. Impact of COVID 19
- 8.3.3. Key market trends, growth factors and opportunities
- 8.3.4. Asia Pacific Artificial Intelligence in Drug Discovery Market by Country 2016 -2026 (USD Million)
- 8.3.5. Asia Pacific Artificial Intelligence in Drug Discovery Market By Application 2016 -2026 (USD Million)
- 8.3.6. Asia Pacific Artificial Intelligence in Drug Discovery Market By End User 2016 -2026 (USD Million)
- 8.3.7. Asia Pacific Artificial Intelligence in Drug Discovery Market By Technology 2016 -2026 (USD Million)
- 8.3.8. Asia Pacific Artificial Intelligence in Drug Discovery Market By Offerings 2016 -2026 (USD Million)
- 8.4. LATIN AMERICA
- 8.4.1. Key Findings
- 8.4.2. Impact of COVID 19
- 8.4.3. Key market trends, growth factors and opportunities
- 8.4.4. Latin America Artificial Intelligence in Drug Discovery Market by Country 2016 -2026 (USD Million)
- 8.4.5. Latin America Artificial Intelligence in Drug Discovery Market By Application 2016 -2026 (USD Million)
- 8.4.6. Latin America Artificial Intelligence in Drug Discovery Market By End User 2016 -2026 (USD Million)
- 8.4.7. Latin America Artificial Intelligence in Drug Discovery Market By Technology 2016 -2026 (USD Million)
- 8.4.8. Latin America Artificial Intelligence in Drug Discovery Market By Offerings 2016 -2026 (USD Million)
- 8.5. MIDDLE EAST AND AFRICA
- 8.5.1. Key Findings
- 8.5.2. Impact of COVID 19
- 8.5.3. Key market trends, growth factors and opportunities
- 8.5.4. Middle East and Africa Artificial Intelligence in Drug Discovery Market by Country 2016 -2026 (USD Million)
- 8.5.5. Middle East and Africa Artificial Intelligence in Drug Discovery Market By Application 2016 -2026 (USD Million)
- 8.5.6. Middle East and Africa Artificial Intelligence in Drug Discovery Market By End User 2016 -2026 (USD Million)
- 8.5.7. Middle East and Africa Artificial Intelligence in Drug Discovery Market By Technology 2016 -2026 (USD Million)
- 8.5.8. Middle East and Africa Artificial Intelligence in Drug Discovery Market By Offerings 2016 -2026 (USD Million)
9. Competitive Landscape Analysis
- 9.1. Global Artificial Intelligence in Drug Discovery Market Company Revenue, (USD Million), 2016-2019
- 9.2. Global Artificial Intelligence in Drug Discovery Market Company Share, (%), 2016-2019
10. Company Profiles
- 10.1. Microsoft
- 10.2. NVIDIA Corporation
- 10.3. IBM Corporation Atomwise Inc.
- 10.4. DEEP GENOMICS
- 10.5. Numerate
- 10.6. NuMedii Inc.
- 10.7. Envisagenics.
- 10.8. twoXAR Incorporated
- 10.9. OWKIN INC.
- 10.10. XtalPi Inc.
- 10.11. BERG LLC
- 10.12. Cloud Pharmaceuticals Inc.
- 10.13. Insilico Medicine
- 10.14. BenevolentAI Ltd
- 10.15. Exscientia
- 10.16. Cyclica Inc.
- 10.17. Others
11. Appendix
12. List of Tables
13. List of Figures
Summary:
Get latest Market Research Reports on Artificial Intelligence in Drug Discovery . Industry analysis & Market Report on Artificial Intelligence in Drug Discovery is a syndicated market report, published as Global Artificial Intelligence in Drug Discovery Market By Application [Immuno-oncology, Neurodegenerative diseases, Cardiovascular disease, Metabolic diseases and others],By End User [Pharmaceutical & biotechnology companies, Contract research organizations, Research centres and institutes], By Technology[Machine Learning, Computer Vision, Context-Aware Computing and NLP], By Offerings[Services and Softwares]:Market Research Report 2021 : Covid 19 Impact Outlook, Regional Analysis, Competitive. It is complete Research Study and Industry Analysis of Artificial Intelligence in Drug Discovery market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
